Diabeloop announced today that its DBLG2 automated insulin delivery algorithm is now open for prescription with Dexcom G7 and ViCentra Kaleido. The companies now offer their integrated automated insulin delivery system in Germany, with availability to come in the Netherlands soon. Their updated system combines the company’s Kaleido patch pump with Diabeloop’s DBLG2 algorithm and the Dexcom G7 continuous glucose […]
Diabeloop
ViCentra launches smartphone-controlled Kaleido automated insulin patch pump system
ViCentra announced today that it launched its Kaleido smartphone-controlled hybrid closed-loop insulin delivery system in Europe. The new system combines the company’s Kaleido patch pump with Diabeloop’s DBLG2 algorithm and the Dexcom G7 continuous glucose monitor (CGM). It comes on the heels of Diabeloop’s CE mark for the next-generation algorithm paired with G7, announced yesterday. […]
Diabeloop gets CE mark for next-gen algorithm paired with Dexcom G7, ViCentra Kaleido
Diabeloop announced today that it received CE mark approval for its latest automated insulin delivery (AID) platform, DBLG2. CE mark approval comes not long after FDA approval in December 2025. The algorithm initially received CE mark last year but now has European approval for compatibility with next-generation devices. With clearance for DBLG2, integrated with the […]
Sequel Med Tech, Diabeloop to integrate automated insulin delivery algorithm into twiist pump
Sequel Med Tech and Diabeloop today announced a collaboration to integrate a new algorithm into the twiist automated insulin pump. The partnership aims to bring DBLG2, Diabeloop’s newest automated insulin delivery (AID) algorithm, to twiist. DBLG2 picked up FDA clearance last month. Sequel becomes the latest pump maker to adopt the algorithm, with ViCentra planning to […]
Diabeloop wins FDA nod for new automated insulin delivery algorithm
Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance. DBLG2 received authorization as a Class II interoperable automated glycemic controller (i-AGC). Clearance validates the algorithm’s interoperability and could bring more choice to people with diabetes, the company said on LinkedIn. It marks the latest milestone for the company’s […]
ViCentra to launch next-gen closed-loop insulin pump system in Europe next year
ViCentra today announced its plans to kick off the launch of its next-generation hybrid closed-loop automated insulin delivery system. The company plans to launch the new system, utilizing its Kaleido patch pump, in Germany and the Netherlands in early 2026. Launch plans come on the heels of CE mark approval for Diabeloop’s DBLG2 algorithm, which […]
Diabeloop launches insulin delivery algorithm in Germany
Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in Germany. The companies distribute their automated insulin delivery offering through Mediq, a leading European diabetes provider. Mediq serves as the exclusive distributor for the DBLG1 system and the Dana-i pump by Sooil. Paris-based Diabeloop develops therapeutic artificial […]
Diabeloop study highlights disparities in insulin requirements between sexes
Diabeloop reported results from a real-world study that demonstrated important differences between males and females in insulin requirements. The study evaluated more than 9,000 adults with type 1 diabetes across Europe. It utilized data from patients using the Diabeloop Generation 1 (DBLG1) hybrid closed-loop insulin delivery device. Investigators published findings in the Journal of Diabetes […]
ViCentra launches hybrid closed-loop insulin system with Dexcom G6
ViCentra announced today that it launched a hybrid closed-loop automated insulin delivery system that uses the Dexcom G6 CGM. Utrecht, The Netherlands-based ViCentra designed the system to deliver insulin through its Kaleido insulin pump. The Diabeloop DBLG1 algorithm receives input from Dexcom’s G6 continuous glucose monitor. Together, they form an artificial pancreas offering flexible self […]
Diabeloop, EOFlow partner on wearable automated insulin delivery in Europe
Diabeloop and EOFlow announced that they partnered to offer the latter’s EOPatch system with automated insulin delivery in Europe. This partnership combines the EOPatch, a third-party continuous glucose monitor (CGM) and Diabeloop’s automated insulin delivery algorithm. They all integrate into Diabeloop’s currently under-development smartphone app. Paris-based Diabeloop said in a news release that they also […]
